BioTech Stock Alert for NexMed Inc. Issued by MicroStockProfit
07 May 2010 - 7:50PM
MicroStockProfit.com announces an investment report featuring
NexMed Inc. (Nasdaq:NEXM). The report includes financial,
comparative and investment analyses, and industry information you
need to know to make an educated investment decision.
The full report is available at:
www.microstockprofit.com/ads/NEXM
NexMed Inc. (NEXM) is a pharmaceutical and medical technology
company with a focus on developing and commercializing therapeutic
products based on its delivery systems. The Company focuses its
efforts on new and topical pharmaceutical products based on a
penetration enhancement drug delivery technology known as NexACT,
which may enable an active drug to be better absorbed through the
skin. The NexACT transdermal drug delivery technology is designed
to enhance the absorption of an active drug through the skin,
overcoming the skin's natural barrier properties, and enabling high
concentrations of the active drug to rapidly penetrate the desired
site of the skin or extremity.
Message Board Search for NEXM:
http://www.boardcentral.com/boards/NEXM
In the report, the analyst notes:
"NEXM, a specialty CRO with a pipeline of products based on the
NexACT® technology, recently announced that the Canadian
Patent Office has issued a Notice of Allowance for NEXM's patent
application entitled, 'Crystalline Salts of Dodecyl
2-(N,N-Dimethylamino)-Propionate.'
"NEXM recently announced that results from a pre-clinical study
showed significant improvement in the delivery and half life of A6,
a proprietary peptide treatment for ovarian cancer currently in
phase 2 development by Angstrom Pharmaceuticals. Specifically, the
incorporation of NexACT® enabled the dose of A6 to be
cut by half, or from twice per day to once per day delivered
subcutaneously, while achieving the same level of efficacy in the
mouse lung metastasis model."
To read the entire report visit:
www.microstockprofit.com/ads/NEXM
See what investors are saying about NEXM at penny stock
forum
MicroStockProfit.com is a small-cap research and investment
commentary provider. MicroStockProfit.com strives to provide a
balanced view of many promising small-cap companies that would
otherwise fall under the radar of the typical Wall Street investor.
We provide investors with an excellent first step in their research
and due diligence by providing daily trading ideas, and
consolidating the public information available on them. For more
information on MicroStockProfit please visit:
http://www.microstockprofit.com
MicroStockProfit.com Disclosure
MicroStockProfit.com is not a registered investment advisor and
nothing contained in any materials should be construed as a
recommendation to buy or sell any securities. MicroStockProfit.com
is a Web site wholly owned by BlueWave Advisors, LLC. Neither
MicroStockProfit.com nor its affiliates have a beneficial interest
in the mentioned company; nor have they received compensation of
any kind for any of the companies listed in this communication.
Please read our report and visit our Web site,
MicroStockProfit.com, for complete risks and disclosures.
CONTACT: MicroStockProfit.com
Brian Johnson
1-888-307-2850
info@microstockprofit.com
Nexmed (MM) (NASDAQ:NEXM)
Historical Stock Chart
From May 2024 to Jun 2024
Nexmed (MM) (NASDAQ:NEXM)
Historical Stock Chart
From Jun 2023 to Jun 2024